{"id":368166,"date":"2025-11-29T14:00:39","date_gmt":"2025-11-29T08:30:39","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=368166"},"modified":"2025-11-29T13:36:24","modified_gmt":"2025-11-29T08:06:24","slug":"cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/","title":{"rendered":"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares."},"content":{"rendered":"<div style=\"text-align: justify; line-height: 150%;\">\n<p style=\"margin-bottom: 3%;\">Cyril Amarchand Mangaldas (&#8220;<span style=\"font-weight: bold;\">CAM<\/span>&#8216;) acted as the Indian legal counsel to Sudeep Pharma Limited (&#8220;<span style=\"font-weight: bold;\">Company<\/span>&#8221;) on the initial public offering of its equity shares (&#8220;<span style=\"font-weight: bold;\">Offer<\/span>&#8221;). The Offer comprised a fresh issue, and an offer for sale of by the promoter selling shareholders.<\/p>\n<p style=\"margin-bottom: 3%;\">The book running lead managers to the Offer were ICICI Securities Limited and IIFL Capital Services Limited (formerly known as IIFL Securities Limited).<\/p>\n<p style=\"margin-bottom: 3%;\">The Offer opened on Friday, November 21, 2025 and closed on Tuesday, November 25, 2025, and received an overall subscription of 93.71 times, with the portion reserved for qualified institutional buyers being subscribed 213.08 times, as per the data available on the National Stock Exchange of India&#8217;s website. The equity shares of the Company commenced trading on the stock exchanges on Friday, November 28, 2025.<\/p>\n<p style=\"margin-bottom: 3%;\">The Company is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries.<\/p>\n<p style=\"margin-bottom: 3%;\">The transaction was led by <span style=\"font-weight: bold;\">Ravi Dubey<\/span>, Partner (Regional Co-Head &#8211; Capital Markets &#8211; West); with support from <span style=\"font-weight: bold;\">Radhika Pandey<\/span>, Principal Associate; <span style=\"font-weight: bold;\">Esha Gupta<\/span>, Associate; <span style=\"font-weight: bold;\">Anomitra Debnath<\/span>, Associate; <span style=\"font-weight: bold;\">Harshita Pareek<\/span>, Associate; and <span style=\"font-weight: bold;\">Khushi Parekh<\/span>, Associate.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p style=\"font-style: italic;\">Comprising a fresh issue and offer for sale by promoter shareholders. The IPO saw an exceptional overall subscription of 93.71 times, with QIB demand at 213.08 times.<\/p>\n","protected":false},"author":67011,"featured_media":368170,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[93581,30960,74146,93644,85405,93647,93646,93645,93642,93643],"class_list":["post-368166","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-cam-capital-markets","tag-cyril-amarchand-mangaldas","tag-icici-securities","tag-iifl-capital-services","tag-india-ipo-2025","tag-indian-equity-markets","tag-nse-ipo-subscription","tag-pharmaceutical-excipients-ipo","tag-sudeep-pharma-ipo","tag-sudeep-pharma-limited"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares | SCC Times<\/title>\n<meta name=\"description\" content=\"Cyril Amarchand Mangaldas advised Sudeep Pharma Limited on its IPO, which achieved 93.71\u00d7 overall subscription and 213.08\u00d7 QIB participation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares.\" \/>\n<meta property=\"og:description\" content=\"Cyril Amarchand Mangaldas advised Sudeep Pharma Limited on its IPO, which achieved 93.71\u00d7 overall subscription and 213.08\u00d7 QIB participation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-29T08:30:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares.\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/11\\\/29\\\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/11\\\/29\\\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\\\/\"},\"author\":{\"name\":\"Editor\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\"},\"headline\":\"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares.\",\"datePublished\":\"2025-11-29T08:30:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/11\\\/29\\\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\\\/\"},\"wordCount\":199,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/11\\\/29\\\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/CAM-Sudeep-Pharma-IPO.webp\",\"keywords\":[\"CAM Capital Markets\",\"Cyril Amarchand Mangaldas\",\"ICICI Securities\",\"IIFL Capital Services\",\"India IPO 2025\",\"Indian Equity Markets\",\"NSE IPO Subscription\",\"Pharmaceutical Excipients IPO\",\"Sudeep Pharma IPO\",\"Sudeep Pharma Limited\"],\"articleSection\":[\"Law Firms News\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/11\\\/29\\\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/11\\\/29\\\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\\\/\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/11\\\/29\\\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\\\/\",\"name\":\"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares | SCC Times\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/11\\\/29\\\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/11\\\/29\\\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/CAM-Sudeep-Pharma-IPO.webp\",\"datePublished\":\"2025-11-29T08:30:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\"},\"description\":\"Cyril Amarchand Mangaldas advised Sudeep Pharma Limited on its IPO, which achieved 93.71\u00d7 overall subscription and 213.08\u00d7 QIB participation.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/11\\\/29\\\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/11\\\/29\\\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/11\\\/29\\\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/CAM-Sudeep-Pharma-IPO.webp\",\"contentUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/CAM-Sudeep-Pharma-IPO.webp\",\"width\":886,\"height\":590,\"caption\":\"CAM Sudeep Pharma IPO\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/11\\\/29\\\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/author\\\/editor_4\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares | SCC Times","description":"Cyril Amarchand Mangaldas advised Sudeep Pharma Limited on its IPO, which achieved 93.71\u00d7 overall subscription and 213.08\u00d7 QIB participation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/","og_locale":"en_US","og_type":"article","og_title":"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares.","og_description":"Cyril Amarchand Mangaldas advised Sudeep Pharma Limited on its IPO, which achieved 93.71\u00d7 overall subscription and 213.08\u00d7 QIB participation.","og_url":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2025-11-29T08:30:39+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_title":"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares.","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/#article","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/"},"author":{"name":"Editor","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"headline":"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares.","datePublished":"2025-11-29T08:30:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/"},"wordCount":199,"commentCount":0,"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp","keywords":["CAM Capital Markets","Cyril Amarchand Mangaldas","ICICI Securities","IIFL Capital Services","India IPO 2025","Indian Equity Markets","NSE IPO Subscription","Pharmaceutical Excipients IPO","Sudeep Pharma IPO","Sudeep Pharma Limited"],"articleSection":["Law Firms News","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/","url":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/","name":"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp","datePublished":"2025-11-29T08:30:39+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"description":"Cyril Amarchand Mangaldas advised Sudeep Pharma Limited on its IPO, which achieved 93.71\u00d7 overall subscription and 213.08\u00d7 QIB participation.","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp","width":886,"height":590,"caption":"CAM Sudeep Pharma IPO"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares."}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/368166","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=368166"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/368166\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/368170"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=368166"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=368166"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=368166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}